Debt-to-equity of Edgewise Therapeutics, Inc. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Edgewise Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 31 Dec 2025.
  • Edgewise Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 5%, a 9.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Edgewise Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 5% +0.44% +9.8% 31 Dec 2025
Q3 2025 5% +0.46% +10% 30 Sep 2025
Q2 2025 5% +0.06% +1.3% 30 Jun 2025
Q1 2025 5.1% -0.43% -7.8% 31 Mar 2025
Q4 2024 4.5% -1.8% -28% 31 Dec 2024
Q3 2024 4.5% -1.6% -26% 30 Sep 2024
Q2 2024 5% -0.44% -8.1% 30 Jun 2024
Q1 2024 5.5% +0.46% +9.2% 31 Mar 2024
Q4 2023 6.3% +1.4% +29% 31 Dec 2023
Q3 2023 6.1% +1.7% +40% 30 Sep 2023
Q2 2023 5.4% +1.3% +33% 30 Jun 2023
Q1 2023 5% 31 Mar 2023
Q4 2022 4.9% 31 Dec 2022
Q3 2022 4.4% 30 Sep 2022
Q2 2022 4.1% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.